Panacela Labs Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
2ndary - Private
Panacela Labs General Information
Description
Developer of gene therapy drugs intended to treat cancer and other infectious diseases. The company's drugs are used for cancer immunotherapy, chemotherapy sensitizer, anti-infectives, and prostate cancer target therapy, enabling patients to have better treatment and healthy life.
Contact Information
Website
www.panacelalabs.comCorporate Office
- 73 High Street
- Buffalo, NY 14203
- United States
Corporate Office
- 73 High Street
- Buffalo, NY 14203
- United States
Panacela Labs Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Secondary Transaction - Private | 01-Aug-2023 | Completed | Clinical Trials - General | |||
| 4. Early Stage VC | 23-Dec-2015 | Completed | Clinical Trials - General | |||
| 3. Early Stage VC (Series A) | 07-Oct-2011 | Completed | Clinical Trials - General | |||
| 2. Buyout/LBO | 30-Sep-2011 | $12M | $1K | Completed | Startup | |
| 1. Angel (individual) | 18-Jul-2011 | $1K | $1K | Completed | Startup |
Panacela Labs Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Panacela Labs Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Panacela Labs Patents
Panacela Labs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20160024083-A1 | Compounds and methods for treating cancers | Inactive | 14-Mar-2013 | ||
| US-20160368872-A1 | Compounds and methods for treating cancers | Inactive | 14-Mar-2013 | ||
| US-20150272960-A1 | Small molecules inhibiting oncoprotein myc | Active | 12-Oct-2012 | ||
| US-9387213-B2 | Small molecules inhibiting oncoprotein myc | Active | 12-Oct-2012 | ||
| AU-2010310477-A1 | Method for treating androgen receptor positive cancers | Inactive | 23-Oct-2009 | A61K31/404 |
Panacela Labs Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Panacela Labs FAQs
-
When was Panacela Labs founded?
Panacela Labs was founded in 2011.
-
Where is Panacela Labs headquartered?
Panacela Labs is headquartered in Buffalo, NY.
-
What is the size of Panacela Labs?
Panacela Labs has 2 total employees.
-
What industry is Panacela Labs in?
Panacela Labs’s primary industry is Drug Discovery.
-
Is Panacela Labs a private or public company?
Panacela Labs is a Private company.
-
What is Panacela Labs’s current revenue?
The current revenue for Panacela Labs is .
-
How much funding has Panacela Labs raised over time?
Panacela Labs has raised $39.9M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
